American Shared Hospital Q3 revenue rises 2.5% driven by direct patient care services

Reuters11-13
American Shared Hospital Q3 revenue rises 2.5% driven by direct patient care services

Overview

  • American Shared Hospital Services Q3 2025 rev increased 2.5%, driven by direct patient care services

  • Q3 2025 EBITDA increased 42.3%, reflecting improved operational efficiency

  • Company signs 10-year extension for Gamma Knife system with existing health system

Outlook

  • Company expects revenue growth from new Gamma Knife center in Guadalajara, Mexico in Q2 2026

  • American Shared Hospital Services anticipates long-term growth from Rhode Island expansions

  • Company sees continued revenue growth from direct patient care services

Result Drivers

  • DIRECT PATIENT CARE - Revenue growth driven by increased procedures at new radiation therapy center in Puebla, Mexico

  • GAMMA KNIFE REVENUE - Period over period increase in Gamma Knife revenue noted

  • STRATEGIC INITIATIVES - Focus on strategic initiatives and economies of scale to maximize profitability

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Gross Margin

22.10%

Analyst Coverage

  • Wall Street's median 12-month price target for American Shared Hospital Services is $4.50, about 53.6% above its November 11 closing price of $2.09

Press Release: ID:nGNXb7X2MD

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment